Introduction
Surface receptors for the Fc portion of immunoglobulin (Ig) G play a crucial role in the homeostasis of lymphocytes. B cells uniquely express the Fc␥RII subtype of receptor, which has low affinity for IgG but high affinity for immune complexes. [1] [2] [3] In the mouse, Fc␥RII is a 40-kDa transmembrane protein designated as a ␤-chain; it is encoded by a single gene and has two isoforms generated by alternative splicing of a single transcript. 2, [4] [5] [6] In humans, Fc␥RII is encoded by three distinct genes that generate five transcripts. 7 Thus, human B cells express Fc␥RIIB1 and Fc␥RIIB2 receptors, which are structurally and functionally homologous to the murine Fc␥RII␤1 and Fc␥RII␤2, 2, 6, 8 and Fc␥RIIA and Fc␥RIIC receptors, which are not expressed in murine B cells. 8, 9 Fc␥RIIA, Fc␥RIIB, and Fc␥RIIC have homologous extracellular domains that are recognized by anti-CD32 antibodies. 10 In addition to B cells, Fc␥RII receptors are expressed in monocytes, macrophages, neutrophils and platelets, 11 where they generally mediate activation signals. 12, 13 The function of Fc␥RII receptors in B cells has been studied primarily in the context of B cell receptor (BCR) signaling. In mature B lymphocytes, coengagement of Fc␥RIIB and BCR suppresses BCRstimulated activation, 1 and can induce both inhibition of cell growth and apoptosis. 14, 15 These inhibitory effects are mediated by the tyrosine phosphorylation of an immunoreceptor tyrosine-based inhibitory motif (ITIM), [16] [17] [18] influx. 2, 3 Another inhibitory pathway involves activation of the adaptor protein p62 dok and inactivation of mitogen-activated protein kinases (MAPK). 19 Fc␥RIIB receptor can also trigger apoptosis upon homoaggregation, an effect that is independent of the ITIM sequence and involves Bruton's tyrosine kinase (BTK). 3, 20 Mice deficient in Fc␥RII receptors show enhanced antibody production and autoimmunity, 21, 22 but no clear evidence of alteration in early B cell development. 21 Fc␥RII is expressed in human immature B cells that lack surface BCR, 10, 23, 24 but its function in these cells is unknown. In this study, we examined Fc receptor expression and function in BCR − B cell precursors (ie pro-B and pre-B cells). We found Fc receptors to be detectable in a minority of normal pro-B and pre-B cells. Fc␥RII was expressed by leukemic blast cells in two-thirds of cases of childhood B-lineage acute lymphoblastic leukemia (ALL), which results from the clonal expansion of BCR − B cell progenitors, and by most immature B cell lines tested. We found that unlike mature B cells, which express Fc␥RIIB, B-lineage ALL cells express predominantly Fc␥RIIA. Aggregation of these receptors induced tyrosine kinase activity, association of p62 dok with Ras GTPase-activating protein p120 (RasGAP), and marked suppression of cell growth.
Materials and methods

Cells
The bone marrow samples used in this study had been taken from four healthy bone marrow transplant donors and from 57 patients with newly diagnosed B-lineage ALL, aged 1 to 18 years (median, 5 years), with approval by the Institutional Review Board and informed consent obtained from donors, patients, parents, or guardians, as appropriate. The diagnosis of B-lineage ALL was unequivocal by morphologic, cytochemical, and immunophenotypic criteria; in each case, leukemic cells were positive for CD19 and terminal deoxynucleotidyl transferase but lacked surface Ig (sIg). Peripheral blood samples were obtained from three healthy adult donors. Mononuclear cells were collected from the samples by centrifugation on a Lymphoprep density step (Nycomed, Oslo, Norway) and were washed three times in phosphate-buffered saline (PBS) and once in AIM-V medium (Gibco, Grand Island, NY, USA).
In 34 and the myeloid cell line K562. 35 All cell lines were maintained in RPMI-1640 (Whittaker Bioproducts, Walkersville, MD, USA) with 10% fetal calf serum (FCS; Whittaker), l-glutamine, and antibiotics.
We derived stromal cells from the mononuclear cells of normal human or bovine bone marrow, as previously described. [36] [37] [38] [39] The cells were separated as described above and washed three times in RPMI-1640. Stromal layers were prepared in flat-bottomed, 96-well plates (Costar, Cambridge, MA, USA) and fed with RPMI-1640, 10% fetal calf serum (FCS), and 10 −6 m hydrocortisone.
Antibodies and flow cytometry
Monoclonal anti-CD32 antibodies comprised 2E1 (IgG2a; Immunotech, Westbrook, ME, USA), IV. 40 and rabbit antiserum to BTK from Dr ME Conley (St Jude Children's Research Hospital, Memphis, TN, USA). 41 Antibodies used for four-surface staining included anti-CD19 conjugated to allophycocyanin and anti-CD34 conjugated to peridinin chlorophyll protein (both from Becton Dickinson), anti-CD10 conjugated to fluorescein isothiocyanate (FITC; Dako) or goat-anti-human and light chains FITC (Southern Biotechnology Associates, Birmingham, AL, USA) and anti-CD32 (2E1) conjugated to phycoerythrin (PE; Beckman-Coulter, Miami, FL, USA). In some experiments we also used goatanti-mouse IgG Fc FITC (Jackson ImmunoResearch), goat-antimouse IgG2a PE and goat-anti-mouse IgG2b PE (both from Southern Biotechnology Associates). Cell labeling was detected with a FACScalibur flow cytometer equipped with argon ion and red diode lasers, and data analyzed with the CellQuest software (both from Becton Dickinson).
Reverse-transcriptase polymerase chain reaction (RT-PCR)
We determine Fc␥RII expression in B-lineage cells by RT-PCR. 42 Total cellular RNA was extracted by using the RNeasy Mini Kit (Qiagen, Santa Clarita, CA, USA), and RNA concentration was determined with a spectrophotometer set at 260 nm. To obtain cDNA, we performed a first-strand cDNA reaction by using a mixture containing 2 g of RNA, 2.5 m random hexamer (Perkin Elmer, Branchburg, NJ, USA), 10 U/l Moloney murine leukemia virus reverse transcriptase (M-MLV RT; Promega, Madison, WI, USA), 500 m each of dATP, dCTP, dGTP, and dTTP (Promega), 1 U/l RNase inhibitor (Promega), and 1× reverse transcriptase buffer (50 mm TrisHCl (pH 8.3), 75 mm KCl, 3 mm MgCl 2 10 mm DTT). RNA Leukemia was first heated at 70°C for 5 min, and the reaction mixtures were then incubated at 37°C for 90 min.
One l of the cDNA reaction mixture was amplified in a total volume of 100 l containing 10 mm Tris-HCl; 50 mm KCl; 1.5 mm MgCl 2 ; 0.001% gelatin; 200 m each of dATP, dCTP, dGTP, and dTTP; 0.5 m each of 5Ј-primer (sense) and 3Ј-primer (antisense); and 2.5 units of AmpliTaq Gold (Perkin Elmer). Gene sequences obtained from GenBank (National Center for Biotechnology, Bethesda, MD, USA) were used with the Primer3 software (available at www. genome.wi.mit.edu//cgi-bin/primer/primer3.cgi) to design primer pairs (Table 1) . Ten-microliter aliquots of the PCR reaction product were analyzed by electrophoresis on 1-2% (wt/vol) agarose gel with ethidium bromide staining. Positive PCR results for Fc␥RIIA and Fc␥RIIB were confirmed by using a different pair of primers.
Cell culture studies
Before each experiment, we washed the adherent cells with RPMI-1640 to completely remove hydrocortisone. Immature B cells were resuspended in RPMI-1640 with 10% FCS. Two hundred microliters of each cell suspension (10 5 -10 6 cells/ml) were then seeded on to bone marrow stromal cells. [36] [37] [38] [39] In parallel experiments, cells were placed in the empty wells of a 96-well flat-bottomed microtiter plate. For culture experiments, anti-CD32 antibodies and nonreactive control Ig were dialyzed in phosphate-buffered saline (PBS), sterile-filtered, and used at concentrations of 2-10 g/ml. All cell cultures were incubated at 37°C in 5% CO 2 with Ͼ90% humidity. Duplicate experiments were done for each test.
After culture, cells were harvested, suspended in PBS, and passed through a 19-gauge needle to disrupt clumps. Viable cells were enumerated by flow cytometry, as previously described. [36] [37] [38] [39] Cell recovery in test cultures was calculated as a percentage of the cells recovered in control cultures.
Immunoprecipitation and Western blotting
Immunoprecipitation was performed essentially as previously described. 34, 41, 43, 44 Briefly, after exposure to anti-CD32 antibody or control Ig (5-10 g/ml), cells were lysed in 1 ml of ice-cold lysis buffer (50 mm Tris (pH 7.5), 150 mm NaCl, 1% (v/v) Triton X-100, 5 g/ml aprotinin, 1 mm phenylmethyl sulfonyl fluoride, 1 mm EDTA, and 1 mm Na 3 VO 4 ) and centrifuged at 20 000 g for 20 min at 4°C. Supernatants were precleared by 1 h of protein A-or protein G-Sepharose treatment Table 1 Primers used for Fc␥RII transcript amplification by RT-PCR
Transcript
Primer
(30 l of 50% slurry). Antibodies were then added to the cleared lysates, and the mixtures were incubated at 4°C for 2 h. The immune complexes were collected by using protein A-or protein G-Sepharose. For sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), cell lysates and immunoprecipitates were resuspended in sample buffer (10% (v/v) glycerol, 5% 2-mercaptoethanol, 3% (w/v) SDS, 65 mm Tris-HCl (pH 6.8) and 0.002% (w/v) bromophenol blue) and separated on 7.5% or 10% acrylamide gels. 34, 41, 43, 44 After transfer, nitrocellulose or polyvinylidene difluoride filters were incubated first in 5% bovine serum albumin in TBS-T (20 mm Tris (pH 7.6), 137 mm NaCl, 0.1% Tween 20) for 16 h, and then with primary antibodies for 2 h. After washing in TBS-T, the filters were incubated for 1 h with horseradish peroxidase-conjugated sheep anti-mouse Ig or donkey anti-rabbit Ig (Amersham, Arlington Heights, IL, USA). The filters were then washed, incubated with enhanced chemiluminescence detection reagents (Amersham), and exposed to Kodak BioMax MR film (Eastman Kodak, Rochester, NY, USA). The filters were then stripped and reblocked, washed, and reprobed. All experiments were repeated at least three times.
Results
Expression of Fc receptors in immature B cells
We used expression of CD34 and of CD10 to distinguish stages of B cell differentiation among bone marrow CD19 + B cells. [45] [46] [47] [48] [49] In B cells from four normal bone marrow samples, CD32 expression gradually increased with maturation ( Figure 1 
Molecular identification of Fc receptors expressed in immature B cells
We used RT-PCR analysis to identify the type of Fc receptor recognized by anti-CD32 antibodies on immature B cells. All Leukemia five pro-B cell lines studied (RS4;11, KOPN55bi, OP1, REH, and 380) had transcripts from the Fc␥RIIA gene: two distinct RT-PCR products corresponding to Fc␥RIIA1 and Fc␥RIIA2 were detectable in all five cell lines (Figure 2 ). The Fc␥RIIA1 transcript encodes a transmembrane protein with 76 intracellular amino acids, and the Fc␥RIIA2 transcript encodes a protein without the putative transmembrane domain. 10 Fc␥RIIB RT-PCR products were absent from all pro-B cell lines except 380 (Figure 2 ). By contrast, Fc␥RIIB was consistently expressed in the more mature cell lines: one cytoplasmic + pre-B cell line (NALM6) and two sIg + mature B cell lines (Raji and AD; Figure 2 ). NALM6 and Raji also expressed Fc␥RIIA1 and Fc␥RIIA2, whereas AD expressed Fc␥RIIC, a type of receptor that was undetectable in all other cell lines (not shown). In control experiments, we examined Fc receptor RT-PCR products in the two CD32 − cell lines 697 and Ramos, and in the CD32 + myeloid cell line K562: Fc␥RIIA, Fci␥RIIB, and Fc␥RIIC transcripts were absent in both cell CD32 − lines, while K562 expressed Fc␥RIIA RT-PCR products ( Figure 2 and not shown).
The Fc␥RIIA, Fc␥RIIB, Fc␥RIIC receptors have highly homologous extracellular domains. 8, 9 However, one anti-CD32 antibody, IV.3, has been reported to react exclusively with Fc␥RIIA. 55, 56 We found all CD32 + cell lines except AD to be reactive with IV.3; these results were consistent with the results of our RT-PCR studies. To determine whether primary leukemic B cells expressed Fc␥RIIA, we studied six CD32 + ALL cases with the IV.3 antibody: the blast cells of all six cases were reactive with IV.3. The percentage of positive cells and the intensity of staining were identical to or higher than those obtained with the pan-Fc␥RII antibody 2E1 (Figure 3 ). By contrast, IV.3 labeled 37.4% ±2.8% (n = 3) of peripheral blood B lymphocytes expressing CD32 (Figure 3) . These results indicate that Fc␥RIIA is the Fc receptor predominantly expressed in B-lineage ALL cells.
Leukemia
Fc receptor-mediated suppression of B-lineage ALL cell growth
To determine the cellular effects of co-aggregation of Fc␥RII receptors in B-lineage ALL cells, we cultured cells from seven cases of CD32 + primary ALL on bone marrow stromal layers, which are essential to support their viability. 57 We then added an anti-CD32 antibody (2E1) or an isotype-matched nonreactive Ig to the cultures. CD32 ligation suppressed cell recovery in five of the seven cases studied: median cell recovery after 7 days of culture in the presence of 2E1 was 33% (range, 19-72%) of cell recovery in control cultures with an isotype-matched non-reactive Ig. In the remaining two cases, no significant reduction in cell recovery was seen, despite levels of CD32 expression similar to those of the antibodysensitive cases.
Exposure to the anti-CD32 antibody 2E1 also dramatically reduced cell numbers in cultures of the cell lines 380, RS4;11, and KOPN55bi ( Figure 4 ). This effect was less marked in the cell lines OP1 and REH (Figure 4) , consistent with the lower expression of CD32 in these cells. Unexpectedly, the effect of CD32 ligation on NALM6 cells was weak (Figure 4) , despite the high levels of CD32 expression in these cells. Notably, the suppressive effect of anti-CD32 required the presence of stromal layers: ligation of CD32 in cultures without stroma did not significantly alter cell recovery in any of the cell lines. No reduction in the recovery of primary B-lineage ALL cells (n = 2) and 380 cells was observed when 2E1 was replaced by an isotype-matched anti-CD10 antibody (not shown).
Fc receptor-mediated signal transduction in B-lineage ALL cells
Engagement of Fc␥RII receptors induces tyrosine kinase activity in murine mature B lymphocytes, [1] [2] [3] as well as in myelo-monocytic cells. 58, 59 We found that ligation of Fc␥RII receptors in the human immature B cell lines RS4;11 and 380 rapidly induced tyrosine kinase activity, which was was timedependent ( Figure 5 ) and directly correlated with the concentration of 2E1 antibody (not shown). Tyrosine phosphorylation was undetectable in NALM6 cells (not shown), consistent with their insusceptibility to anti-CD32-induced growth suppression. The relationship between tyrosine kinase activity and growth suppression was also evident in experiments comparing the effects of the two anti-CD32 antibodies 2E1 and KB61. 2E1 induced tyrosine phosphorylation without further cross-linking, and suppressed cell growth. In contrast, KB61 required cross-linking with a secondary antibody to produce detectable tyrosine phosphorylation (not shown). In cultures of 380, treatment with KB61 did not decrease cell recovery. After KB61 was cross-linked with a donkey anti-mouse F(abЈ) 2 secondary antibody, mean (± s.d.) cell recovery decreased to 22.9% ± 8.5% in six experiments.
Exposure of RS4;11 and 380 cells to anti-CD32 (2E1) induced tyrosine phosphorylation of a protein of approximately 44 kDa immunoprecipitated by the anti-Fc␥RIIA IV.3 antibody (Figure 6 ). No Fc␥RIIA tyrosine phosphorylation was detected in parallel experiments performed with the NALM6 cell line (Figure 6 ). In addition to tyrosine phosphorylation of Fc␥RIIA itself, other early signaling events induced by CD32 ligation included tyrosine phosphorylation of the transmembrane protein CD19, the adaptor protein CBL, and the regulatory component of PI 3-kinase (PI3-K p85; Figure 6 ). CD32 lig- CD32 ligation induces rapid and transient tyrosine phosphorylation in B-lineage ALL cells. RS4;11 cells were exposed to anti-CD32 (2E1; 10 g/ml) for the times indicated. Cell lysates were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was probed with the anti-phosphotyrosine antibody 4G10. Molecular mass markers (in kDa) are indicated.
ation also induced tyrosine phosphorylation of the tyrosine kinase SYK, but not the tyrosine kinase BTK (not shown).
Next, we investigated whether ligation of Fc␥RIIA would lead to activation of known pathways of cell growth inhibition. RasGAP is a GTPase-activating protein that enhances the intrinsic GTPase activity of Ras, causing the hydrolysis of bound GTP to GDP. 60 After tyrosine phosphorylation, the adaptor protein p62 dok binds to RasGAP and modulates its activity, 61 an event that may lead to inactivation of MAPK and inhibition of cell growth. 19 Exposure of RS4;11 cells to either 2E1 or IV.3 antibodies induced tyrosine phosphorylation of p62 dok (Figure 7a ). Fc␥RIIA ligation also induced the appearance of one tyrosine-phosphorylated protein of 60-65 kDa that coprecipitated with RasGAP (Figure 7b ). The protein obtained in p62 dok immunoprecipitates had an identical shape and migration pattern (Figure 7c) , suggesting that the tyrosine phosphorylated protein that associated with RasGAP after CD32 ligation is p62 dok . Finally, we also found that Fc␥RIIA ligation induced tyrosine phosphorylation of the phosphatidylinositol 5-phosphatase SHIP, as previously observed in monocytes (not shown).
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Discussion
The family of cell-surface receptors for the Fc portion of IgG mediate important physiologic functions. [1] [2] [3] The function of the Fc receptors in B cells has been closely linked to their ability to suppress BCR-mediated signaling. [1] [2] [3] Much less is known about the expression and function of Fc receptors in immature B cells which lack surface BCR, particularly those of human origin. In this study, we found that human immature B cells predominantly express Fc␥RIIA, and that ligation of these receptors induces marked suppression of B-lineage ALL cell growth -a function not previously known. Although we
Leukemia
Figure 6
Early signaling events induced by CD32 ligation in Blineage ALL cells. RS4;11 (a-d), 380 (a) and NALM6 (a) cells were exposed to nonreactive IgG2 or anti-CD32 (2E1) for 5 min. detected Fc receptor expression in a fraction of normal pro-B and pre-B cells, the rarity of CD32 expression among these cells precluded the study of CD32-mediated signals. However, in view of the powerful effects of CD32 ligation on their leukemic counterparts, it is plausible that normal pro-B and pre-B cells expressing CD32 might also be susceptible to inhibitory signals mediated by this receptor.
A few early studies have assessed the expression of Fc receptors in leukemic immature B cells from patients with ALL, with wide ranging results. 23, 24, 63 The results of our study indicate that most B-lineage ALL blast cells express Fc receptors of the Fc␥RIIA type, in line with a previous study of cell lines. 10 It is noteworthy that induction of tyrosine kinase activity and the cellular effects of exposure to anti-CD32 antibodies were particularly evident in the RS4; 11 cell line, which expresses Fc␥RIIA but does not express detectable Fc␥RIIB and Fc␥RIIC. Inhibitory effects mediated by Fc␥RIIA are unexpected, because in other cell types, engagement of these receptors usually results in activation signals. For CD32 ligation induces tyrosine phosphorylation of p62 dok and its association with RasGAP. (a) RS4;11 cells were exposed to nonreactive IgG2, anti-CD32 (2E1), or anti-CD32 (IV.3) plus F(abЈ) 2 fragment of a donkey anti-mouse Ig ('anti-mIg') for 5 min. p62 dok was immunoprecipitated with a specific antibody. Immunoprecipitates were separated by SDS-PAGE and transferred to a nitrocellulose membrane. After stripping, the membrane was reprobed with the anti-p62 dok antibody. (b) RS4;11 cells were exposed to nonreactive IgG2 and anti-CD32 (2E1) for 5 min. RasGAP was immunoprecipitated with a specific antibody; immunoprecipitates were separated and transferred as in (a). The membrane was probed with the anti-phosphotyrosine antibody 4G10. One tyrosine phosphorylated protein of approximately 60-65 kDa coprecipitated with RasGAP (arrow). After stripping, the membrane was reprobed with the anti-RasGAP antibody. (c) RS4;11 cells were exposed to anti-CD32 (2E1) for 5 min. RasGAP and p62 dok were immunoprecipitated with specific antibodies. Immunoprecipitates were separated and transferred as in (a). The membrane was probed with the anti-p62 dok antibody.
example, Fc␥RIIA engagement mediates phagocytosis and release of inflammatory mediators in macrophages, 12 and aggregation in platelets.
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CD32-mediated growth suppression was associated with the induction of tyrosine kinase activity. Two observations point to a link between the biochemical and cellular effects triggered by CD32 ligation. First, the antibody KB61 induced both tyrosine kinase activity and inhibition of cell growth only when cross-linked with an anti-mouse secondary antibody. Without cross-linking, neither effect was detectable. Second, CD32 ligation induced both tyrosine kinase activity and suppression of cell growth in all immature B cell lines tested except NALM6, a cell line in which neither effect was detected despite high expression of CD32. Among the signaling events induced by CD32 ligation in B-lineage ALL cells, tyrosine phosphorylation of p62 dok and its association with RasGAP together with SHIP phosphorylation could be directly related to CD32-mediated inhibition of cell growth. These signaling events recapitulate those following Fc␥RIIB inhibition of BCR-mediated activation in murine mature B cells. 19 We used stroma-supported cultures of primary leukemic cells to assess the effects of CD32 ligation on cell growth. Stromal cells are essential to the in vitro survival of leukemic cells obtained directly from patients, which rapidly undergo apoptosis in the absence of stromal support. 38, 57 Interestingly, the inhibitory effects of CD32 ligation on continuously growing cells lines, which do not require stromal cell support, were seen only when these cells were cultured on stroma. We think it unlikely that the effects were caused by stroma-secreted factors induced by binding of anti-CD32 antibodies to stroma, because the inhibitory effects were seen only in cell lines that express CD32 and are susceptible to CD32-triggered tyrosine kinase activity. Therefore, we conclude that the effects were caused by a direct interaction between anti-CD32 antibodies and immature lymphoid cells rather than caused indirectly by stimulation of stromal cells. Although the precise relationship between CD32 ligation and microenvironmental stimuli in inducing inhibition of cell growth is still unknown, it is noteworthy that we had previously observed a similar phenomenon in our studies of the growth-suppressive effects of CD38 ligation in immature B cells. 37 As current cure rates for childhood ALL are at a plateau of approximately 70-80% worldwide [64] [65] [66] [67] [68] and those of adult ALL are at much lower levels, [69] [70] [71] it is obvious that innovative therapeutic agents are needed to eradicate apoptosis-resistant residual and recurrent disease. 72, 73 In this regard, the identification of a surface molecule capable of eliciting inhibitory signals in ALL cells within the bone marrow microenvironment has practical implications, as such molecules and signaling pathways are potential targets of novel antileukemic therapies. 74, 75 
